Analysis for iShares MSCI Emerging Markets ETF
Analysis summary
iShares MSCI Emerging Markets ETF (EEM) currently has a total score of 59 points, placing it in the neutral range. The score is made up of Performance (44), Stability (77) and Trend (70). The profile is clearly uneven: Stability stands out while Performance is more neutral.
Performance scores 44 points (neutral). Key strength: 1Y return at 37.7 %. Weaker metric: 5Y return at 6.6 %. This points to a sharper upswing more recently.
Stability scores 77 points (strong). Key strength: return/volatility ratio at 2.12. Main drag: CAGR/drawdown ratio at 0.17. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 70 points (strong). Key strength: 12M momentum at 31.8 %. Even the weakest metric remains solid in absolute terms: SMA50 distance at 6.2 %.
Overall, the picture is mixed: Stability does the heavy lifting while Performance holds the score back. On a metric level, return/volatility ratio stands out, while 5Y return lags.
(Historical evaluation, not investment advice.)
Metrics
Stability
FAQ
- What investor type does iShares MSCI Emerging Markets ETF fit best in FoxScore?
- iShares MSCI Emerging Markets ETF fits a more defensive investor type in FoxScore: stability is the strongest part of the profile. That points to comparatively smaller drawdowns and calmer swings versus the universe — but prices can still fall.
- How meaningful is the available history for iShares MSCI Emerging Markets ETF?
- iShares MSCI Emerging Markets ETF currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.